Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?
作者信息
Schleiss Mark R
出版信息
J Infect Dis. 2011 Jun 1;203(11):1513-6. doi: 10.1093/infdis/jir144.
Abstract
摘要
相似文献
1
Could therapeutic vaccination of cytomegalovirus-seropositive persons prevent reinfection and congenital virus transmission?巨细胞病毒血清反应阳性者的治疗性疫苗接种能否预防再感染和先天性病毒传播？
J Infect Dis. 2011 Jun 1;203(11):1513-6. doi: 10.1093/infdis/jir144.
2
Vaccination against the human cytomegalovirus.人巨细胞病毒疫苗接种。
Vaccine. 2019 Nov 28;37(50):7437-7442. doi: 10.1016/j.vaccine.2018.02.089. Epub 2018 Apr 3.
3
Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.模拟疫苗接种对先天性巨细胞病毒感染流行病学的潜在影响。
Vaccine. 2014 Jun 24;32(30):3780-6. doi: 10.1016/j.vaccine.2014.05.014. Epub 2014 May 14.
4
A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.复制缺陷型人巨细胞病毒疫苗可诱导类似于自然感染的体液免疫应答。
J Virol. 2019 Nov 13;93(23). doi: 10.1128/JVI.00747-19. Print 2019 Dec 1.
5
Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.一种纯化的重组糖蛋白B疫苗对豚鼠先天性巨细胞病毒感染和疾病的保护作用。
J Infect Dis. 2004 Apr 15;189(8):1374-81. doi: 10.1086/382751. Epub 2004 Apr 1.
6
Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.增进我们对母体保护性免疫的理解，以此作为开发疫苗以减少先天性巨细胞病毒感染的指导。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.00030-18. Print 2018 Apr 1.
7
Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.中和恒河猴巨细胞病毒的白细胞介素-10 可减少水平传播并改变长期免疫。
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13036-13041. doi: 10.1073/pnas.1903317116. Epub 2019 Jun 12.
8
Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.先天性巨细胞病毒传播的动物模型：对疫苗开发的启示
J Infect Dis. 2020 Mar 5;221(Suppl 1):S60-S73. doi: 10.1093/infdis/jiz484.
9
Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection.预防先天性巨细胞病毒感染的疫苗接种数学模型综述。
J Infect Dis. 2020 Mar 5;221(Suppl 1):S86-S93. doi: 10.1093/infdis/jiz402.
10
Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.预防先天性巨细胞病毒病疫苗的前景。
Med Microbiol Immunol. 2016 Dec;205(6):537-547. doi: 10.1007/s00430-016-0472-z. Epub 2016 Aug 12.
引用本文的文献
1
Longitudinal Kinetics of Cytomegalovirus-Specific T-Cell Immunity and Viral Replication in Infants With Congenital Cytomegalovirus Infection.先天性巨细胞病毒感染婴儿中巨细胞病毒特异性T细胞免疫和病毒复制的纵向动力学
J Pediatric Infect Dis Soc. 2016 Mar;5(1):14-20. doi: 10.1093/jpids/piu089. Epub 2014 Sep 11.
2
Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.模拟疫苗接种对先天性巨细胞病毒感染流行病学的潜在影响。
Vaccine. 2014 Jun 24;32(30):3780-6. doi: 10.1016/j.vaccine.2014.05.014. Epub 2014 May 14.
3
Molecular and biological characterization of a new isolate of guinea pig cytomegalovirus.豚鼠巨细胞病毒新分离株的分子和生物学特性。
Viruses. 2014 Jan 27;6(2):448-75. doi: 10.3390/v6020448.
4
Cytomegalovirus in the neonate: immune correlates of infection and protection.新生儿巨细胞病毒感染：感染与保护的免疫关联
Clin Dev Immunol. 2013;2013:501801. doi: 10.1155/2013/501801. Epub 2013 Aug 19.
5
Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus.用于人类巨细胞病毒的基于质粒 DNA 的预防性疫苗的免疫原性和安全性的临床前评估。
Hum Vaccin Immunother. 2012 Nov 1;8(11):1595-606. doi: 10.4161/hv.21225. Epub 2012 Aug 24.
本文引用的文献
1
Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.糖蛋白 B 疫苗能够增强慢性感染女性巨细胞病毒的抗体和 CD4 T 细胞反应。
J Infect Dis. 2011 Jun 1;203(11):1534-41. doi: 10.1093/infdis/jir138.
2
Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection.先天性巨细胞病毒感染归因于原发性与非原发性母体感染。
Clin Infect Dis. 2011 Jan 15;52(2):e11-3. doi: 10.1093/cid/ciq085.
3
Detection of a single identical cytomegalovirus (CMV) strain in recently seroconverted young women.新近血清转化的年轻女性中单一相同巨细胞病毒（CMV）株的检测。
PLoS One. 2011 Jan 10;6(1):e15949. doi: 10.1371/journal.pone.0015949.
4
Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.表达 NKG2D 受体配体的重组小鼠巨细胞病毒减毒并具有改善的疫苗特性。
J Clin Invest. 2010 Dec;120(12):4532-45. doi: 10.1172/JCI43961. Epub 2010 Nov 22.
5
Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines.能否让疫苗做得更好？利用 BAC 遗传学来开发更有效的巨细胞病毒疫苗。
J Clin Invest. 2010 Dec;120(12):4192-7. doi: 10.1172/JCI45250. Epub 2010 Nov 22.
6
Update on the current status of cytomegalovirus vaccines.巨细胞病毒疫苗的最新研究进展。
Expert Rev Vaccines. 2010 Nov;9(11):1303-14. doi: 10.1586/erv.10.125.
7
Cytomegalovirus viruria and DNAemia in healthy seropositive women.巨细胞病毒尿症和病毒血症在健康血清阳性妇女中的研究。
J Infect Dis. 2010 Dec 15;202(12):1800-3. doi: 10.1086/657412. Epub 2010 Nov 4.
8
Cytomegalovirus gN genotypes distribution among congenitally infected newborns and their relationship with symptoms at birth and sequelae.巨细胞病毒 gN 基因型在先天性感染新生儿中的分布及其与出生时症状和后遗症的关系。
Clin Infect Dis. 2010 Jul 1;51(1):33-41. doi: 10.1086/653423.
9
Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus.CD8+ T 细胞的逃逸对于巨细胞病毒的再次感染至关重要。
Science. 2010 Apr 2;328(5974):102-6. doi: 10.1126/science.1185350.
10
Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population.在高巨细胞病毒免疫的母体人群中，人巨细胞病毒再感染与宫内传播有关。
Am J Obstet Gynecol. 2010 Mar;202(3):297.e1-8. doi: 10.1016/j.ajog.2009.11.018. Epub 2010 Jan 13.
Zotero 插件